
Sign up to save your podcasts
Or
Joining us on this episode is Tom Neyarapally, co-founder and CEO of Archetype Therapeutics, an exciting new AI-driven company in the drug discovery space. Archetype is an AI-native biotech pioneering the use of generative chemogenomics and patient clinicogenomic data to virtually screen billions of potential drug candidates each day.
TPM E47 highlights >
Episode 47 links:
4.7
77 ratings
Joining us on this episode is Tom Neyarapally, co-founder and CEO of Archetype Therapeutics, an exciting new AI-driven company in the drug discovery space. Archetype is an AI-native biotech pioneering the use of generative chemogenomics and patient clinicogenomic data to virtually screen billions of potential drug candidates each day.
TPM E47 highlights >
Episode 47 links:
421 Listeners
32,124 Listeners
21,896 Listeners
43,776 Listeners
9,529 Listeners
112,603 Listeners
6,015 Listeners
9,790 Listeners
32 Listeners
20 Listeners